Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial

PURPOSE: To evaluate efficacy and toxicity clinical in the intensified treatment of locally advanced squamous cell carcinoma of the head and neck (SCCHN) with the combination of chemotherapy, the EGFR antibody cetuximab, and intensity-modulated radiation therapy (IMRT) in a concomitant boost concept...

Descripción completa

Detalles Bibliográficos
Autores principales: Jensen, Alexandra D, Krauss, Jürgen, Potthoff, Karin, Simon, Christian, Nikoghosyan, Anna V, Lossner, Karen, Debus, Jürgen, Münter, Marc W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342898/
https://www.ncbi.nlm.nih.gov/pubmed/22472064
http://dx.doi.org/10.1186/1748-717X-7-57

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342898/
https://www.ncbi.nlm.nih.gov/pubmed/22472064
http://dx.doi.org/10.1186/1748-717X-7-57

Ejemplares similares